{"ok":true,"trend":{"id":101228,"platform":"news","region":"global","key":"can hims & hers health (hims) stay cheap as sales face scrutiny?","title":"Can Hims & Hers Health (HIMS) Stay Cheap As Sales Face Scrutiny?","url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxNRW5UMkpmTFVjOGlMVDJoWk9RVWd5VFc1WnRKbWx0ekItRmp3RGFYcHl4R3N0TEQxdkpWX2NOYzByeEZrQzVwbUZkMjhxRW13Y1gzZjJvNWVzNlIyTGRLX1cwRWZabEJuWmlscUktaGh6eFNqY0R4TndqU25hRW5DbDdzTkFiOElzWlJiYldzelA?oc=5","first_seen":"2026-09-27T11:17:45.585616Z","last_seen":"2026-09-27T12:39:45.684752Z","last_rank":28,"peak_rank":22,"last_volume":null,"peak_volume":0,"seen_count":2,"score":25.27,"category_hint":"health","section":"health","category":"health","summary":"Hims & Hers Health, the telehealth company known for prescription and wellness products, is trading at a low valuation while questions mount over the durability of its sales. Analysts and investors are debating whether the stock's cheap price reflects genuine risk to revenue growth, particularly around its popular weight-loss and telehealth offerings, or a buying opportunity.","why":"Investors are weighing whether the low share price signals real problems for the company's sales or an undervalued opportunity.","tone":"neutral","entities":["Hims & Hers Health","HIMS"],"summarized_at":"2026-09-27T11:18:55.051319Z","meta":{"via":"scan","lang":"en","term":"health","source":"Yahoo Finance","generic":0.1,"published":"Sun, 27 Sep 2026 07:08:20 GMT"},"nw":0.39,"promo":0.03,"kind":"news_event","importance":1.5,"hidden":false,"hide_reason":null,"judged_at":"2026-09-27T11:17:46.180751Z","title_en":"Hims & Hers Valuation Questioned as Sales Face Scrutiny","section_name":"Health","category_name":"Health","timeline":[{"captured_at":"2026-09-27T11:17:45.585616Z","rank":22,"volume":null},{"captured_at":"2026-09-27T12:39:45.684752Z","rank":28,"volume":null}],"posts":[{"platform":"news","url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxNRW5UMkpmTFVjOGlMVDJoWk9RVWd5VFc1WnRKbWx0ekItRmp3RGFYcHl4R3N0TEQxdkpWX2NOYzByeEZrQzVwbUZkMjhxRW13Y1gzZjJvNWVzNlIyTGRLX1cwRWZabEJuWmlscUktaGh6eFNqY0R4TndqU25hRW5DbDdzTkFiOElzWlJiYldzelA?oc=5","author":"Yahoo Finance","title":"Can Hims & Hers Health (HIMS) Stay Cheap As Sales Face Scrutiny?","snippet":null,"posted_at":"2026-09-27T07:08:20Z","likes":null}],"elsewhere":[],"window":"7d"}}